Authors: WOMER RB ANUNCIATO KR CHEHRENAMA M

Citation: Rb. Womer et al., ORAL METHOTREXATE AND ALTERNATE-DAY PREDNISONE FOR LOW-RISK LANGERHANS CELL HISTIOCYTOSIS, Medical and pediatric oncology, 25(2), 1995, pp. 70-73